Serogroup B Neisseria meningitidis (MenB) is a major cause of severe sepsis and invasive meningococcal disease, which is associated with 5-15% mortality and devastating long-term sequelae. Neisserial adhesin A (NadA), a trimeric autotransporter adhesin (TAA) that acts in adhesion to and invasion of host epithelial cells, is one of the three antigens discovered by genome mining that are part of the MenB vaccine that recently was approved by the European Medicines Agency. Here we present the crystal structure of NadA variant 5 at 2 Å resolution and transmission electron microscopy data for NadA variant 3 that is present in the vaccine. The two variants show similar overall topology with a novel TAA fold predominantly composed of trimeric coiled-coils with three protruding wing-like structures that create an unusual N-terminal head domain. Detailed mapping of the binding site of a bactericidal antibody by hydrogen/deuterium exchange MS shows that a protective conformational epitope is located in the head of NadA. These results provide information that is important for elucidating the biological function and vaccine efficacy of NadA.
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meningitis | coiled coil | thermostability | hydrogen-deuterium exchange | trimeric autotransporter adhesin T he Gram-negative encapsulated bacterium Neisseria meningitidis causes severe sepsis and meningococcal meningitis. Invasive meningococcal disease (IMD) is associated with 5-15% mortality; furthermore, devastating long-term sequelae such as amputations, hearing loss, and neurodevelopmental disabilities are observed in 11-19% of IMD survivors (1) . Meningococcal serogroups are distinguished by the composition of their capsular polysaccharides. The five serogroups most commonly associated with invasive disease are A, B, C, W, and Y. (2) . Effective mono-or polyvalent-conjugated polysaccharide vaccines against N. meningitidis serogroups A, C, W, and Y have been available since the early 1990s (3). However, serogroup B meningococcus (MenB) is responsible for the majority of endemic and epidemic meningococcal disease in developed countries (4) (5) (6) . The development of an efficient capsular polysaccharide-based vaccine against MenB has been hampered by potential autoimmunity issues, namely, the structural similarity between the MenB capsular polysaccharide and the neuraminic acid present on the surface of human fetal neural tissues (7) .
In early 2013 the European Medicines Agency approved 4CMenB, to our knowledge the first broadly protective vaccine against MenB, for the prevention of IMD in all age groups. 4CMenB is a multicomponent vaccine formulation composed of three surface-exposed meningococcal proteins originally identified by the reverse vaccinology approach (8) plus outer membrane vesicles from the New Zealand epidemic clone. The three antigenic proteins are factor H-binding protein (fHbp), neisserial heparin-binding antigen (NHBA), and neisserial adhesin A (NadA) (9, 10) .
The gene encoding NadA is present in ∼30% of pathogenic meningococcal isolates and is associated mostly with strains that belong to three of the four hypervirulent serogroup B lineages (11) (12) (13) (14) . NadA expression levels can vary among isolates by more than 100-fold, and its expression is up-regulated in vivo by nichespecific signals (15) . NadA induces high levels of bactericidal antibodies in humans (16) (17) (18) and is recognized by serum antibodies of children convalescent after IMD (19), suggesting that it is expressed and is immunogenic during IMD. Two main genetically distinct groups of NadA have been identified that share overall amino acid sequence identities of 45-50%. Group I includes the three most common variants (NadA1, NadA2, and NadA3, the latter being the vaccine variant), which share ∼95% sequence identity and are immunologically cross-reactive (11) . Group II includes three rarer variants: NadA4, primarily associated with carriage strains (11); NadA5, found mainly in strains of clonal complex 213 (20, 21); and NadA6 (Fig. S1A) ; these three share ∼90% sequence identity ( Fig. S1B) 
(22).
Functionally, NadA3 expressed on the surface of Escherichia coli promotes adhesion to and invasion of Chang epithelial cells (23). This adhesive activity has been mapped, at least partially, to an N-terminal region extending to residue T132 (23, 24). Recently, interactions of NadA3 with β-1 integrin (25) and with the heat shock protein Hsp90 (26) have been reported.
Structurally, NadA belongs to the class of trimeric autotransporter adhesins (TAAs) (27, 28), which are known to Significance Serogroup B meningococcus (MenB) causes severe sepsis and invasive meningococcal disease, particularly affecting young children and adolescents. The genome-derived vaccine 4CMenB that targets MenB, has now been approved in over 30 countries worldwide. Here we report the crystal structure of the trimeric autotransporter Neisserial adhesin A (NadA), one of the three protein antigens included in 4CMenB, and the epitope mapping of a bactericidal mAb monoclonal antibody that targets the functional head domain of NadA. These results provide important insights into the structure and vaccine-induced immune response of this meningococcal antigen and may inform the engineering of improved immunogens by structure-based design.
mediate adhesion through interaction with extracellular matrix proteins and are involved in invasion of target cells (29). TAAs are obligate homotrimers, and accordingly the recombinant NadA3 vaccine antigen, lacking the C-terminal membrane anchor region, forms soluble, stable trimers (23, 30). TAAs generally are made of a conserved C-terminal integral membrane β-barrel, which anchors the proteins to the outer membrane, and an N-terminal "passenger" domain responsible for adhesion (31). The TAA passenger domain typically is made of a central α-helical domain (stalk) that forms coiled-coil structures and a distinct N-terminal domain (head) that is mainly responsible for binding to host cellular receptors.
Here we present the X-ray structure of a large ectodomain fragment of NadA5 and a structural analysis by transmission electron microscopy (TEM) of the vaccine variant NadA3. In addition, epitope mapping shows that the head of NadA3 contains immunogenic regions responsible for the generation of a protective bactericidal response.
Results
NadA Coiled-Coil Composition Greatly Influences Protein Thermostability.
Extensive attempts to crystallize NadA3 using the vaccine construct that includes the predicted head and entire stalk domains (30) were unsuccessful. We hypothesized that a long, flexible stalk might have hindered crystallization. Therefore, multiple NadA3 constructs were generated, each with a progressively shorter stalk (Fig. S2) , and these constructs were screened for increased thermostability using differential scanning calorimetry (DSC), because higher melting-point (T m ) values may increase the probability of crystallization (32). Further, based on sequence alignments, corresponding NadA4 and NadA5 constructs were designed and tested. The DSC screens did not reveal T m gains in the NadA3 constructs (Fig. S3A ) but showed remarkably higher thermostability in NadA4 and NadA5 (ΔT m ∼14°C) (Fig. 1) . Five additional NadA4 constructs with progressive C-terminal truncations did not yield further T m increases, and a NadA4 "head-only" construct was not detected by DSC, suggesting that the head domain is unable to fold when isolated from the stalk (Fig. S3B) . Ultimately, reproducible diffraction-quality crystals were obtained only from the construct NadA5 A24-R220 .
High-Resolution Structure of NadA. The crystal structure of NadA5 was solved at 2 Å resolution by single anomalous dispersion (SAD), using a dataset collected at 1.54 Å wavelength on a crystal soaked in a solution containing 1 M NaI (Table S1 ). The crystals of NadA5 belonged to space group R 3 2 (H), had a solvent content of 60%, and contained one monomer of NadA5 in the asymmetric unit positioned on the crystallographic threefold axis along c (Fig. S4) . The NadA5 biological homotrimer was visualized using the two threefold crystallographic symmetry operators along the c axis of the crystal ( Fig. 2A) .
Overall, the structure of NadA5 (residues A24-R220) is made of an elongated coiled-coil, or stalk, that runs from the N terminus to the C terminus and extends in length for roughly 220 Å with an average width of 15 Å in its central stalk region. A broader N-terminal region (width ∼40 Å) forming the head domain is readily apparent (Fig. 2) . High-quality electron density was observed allowing residues P27-A137 to be fitted with confidence (Fig. S5) . However, after residue A137 only low σ-level and discontinuous electron densities were observed, preventing confident fitting Fig. 1 . NadA4 and NadA5 show high thermostability. DSC profiles show a ΔT m of ∼14°C between the full-length construct of NadA3 (blue) and constructs of NadA4 and NadA5 (green and red). Fig. 2 . The crystal structure of NadA5. (A) Cartoon diagram of trimeric NadA5. Monomeric NadA5 that occupies the asymmetric unit is colored in blue for the coiled-coil region and in green for the wing-like insertion of the head; two symmetry-related molecules are shown in gray. Red spheres show the positions of iodide ions buried in the coiled-coil, and yellow meshes around these spheres show anomalous difference electron densities. The large rectangular gray-shaded outline shows the region of low-σ electron density. (B) Top view of NadA5, looking down the c axis, after rotation of 90°around x. (C) A zoomed-in view of the region of the insertion in the head of NadA5 (boxed region in A). The ribbon of NadA is colored as in A, and a superimposed α-helix, chosen from the trimeric transcription factor GCN4 (PDB ID code 4DME) to show the continuity of the coiled-coil of NadA5 around the region of the interruption, is shown as a semitransparent red ribbon. Yellow and magenta sticks depict NadA heptad residues a and d, respectively, and the distance in angstroms between their Cα carbons is shown.
of the polypeptide chain in this region. Further observations of clear electron density toward the C terminus revealed another continuous stretch spanning T199-A210, although discontinuous, low σ-level electron densities in the region between A137 and T199 retained a few notable peaks with threefold symmetry features (Fig. S5 ). This observation suggests that the three helices of the NadA5 stalk are less stable in this region, likely resulting in partial unwinding of the coil and therefore in some flexibility and disorder. These conclusions are also supported by the observation that the fragments of the last visible residues, T199-A210, are arranged as short uncoiled helices, with a relatively large diameter of ∼47 Å ( Fig. 2A) .
The N Terminus of NadA5 Presents a Previously Unidentified Head Domain Organization. In contrast to other TAAs, NadA lacks a truly independent globular head domain. Instead, NadA possesses an almost exclusively coiled-coil architecture that can be divided in two fragments (made of residues A34-I48 and L85-A137, respectively) separated by a sequence insertion (residues N49-G84) ( Fig. 2 and Fig. S6 ). Quite remarkably, this interruption does not result in a discontinuity or structural perturbation of the coiled-coil, and it forms wing-like structures (three per trimer) that protrude from the stalk and pack against the N-terminal helices. Although this arrangement differentiates NadA from other TAAs, the overall larger dimensions of the Nterminal region are reminiscent of the typical TAA architecture, and the peculiar structure of the head domain might reflect particular host-receptor specificity.
N at Position d (N@d) Layers in the NadA Coiled-Coil. The coiled-coil of NadA5 begins in the N terminus with the first heptad repeat formed by residues A34 (position a) and A37 (position d) (Fig.  S6) . A second heptad is made of V41 at position a and N44 at position d, with N44 being the first of four total Asn residues observed in position d of the heptads (Fig. 3) . As previously observed for other TAAs (33) , the N at position d layers (termed "N@d" layers) are found to coordinate ions in the buried core of the hydrophobic coiled-coil. For NadA, because of the high concentration of NaI in the crystal soaking experiments, we observed the presence of buried iodide ions. Residues I48 (a) and L85 (d) form the third heptad repeat, which, as described above, is characterized by a remarkably long insertion (36 residues) or interruption that replaces the expected bc residue pair of the heptad with residues 49-84 ( Fig. 2C and Fig. S6A ). Finally, a continuous series of seven additional canonical heptads can be observed for the remaining visible stalk, spanning residues L85-N134.
NadA Has No Close Structural Homologs. A database search with the DALI server (34) identified several coiled-coil protein structures, such as tropomyosin, myosin, and vimentin, but the only TAA structure identified as similar to NadA, although with high rmsd values (>15 Å), was SadA from Salmonella enterica. This result suggests that, although the helical fold is a predominant quality that biases the DALI selections, NadA has no overall close structural homologs (Fig. S7 ).
Electron Microscopy of NadA3 Shows a Conserved Overall Topology.
NadA3 was studied by negative stain TEM to determine if it possessed the same overall topology as NadA5. NadA3 was readily identified in TEM images (Fig. 4A) , and single boxed NadA3 particles first were band-pass filtered to increase the signal-tonoise ratio, then were rotationally and translationally aligned, and then centered before undergoing multivariate statistical analysis for classification (35). Reference-free 2D class averages showed that NadA3 has a thin elongated structure that is broader at one end, likely corresponding to the N-terminal head domain (Fig.  4B ). The NadA3 molecules displayed a maximum length of ∼300 Å and were observed both in linear conformations (similar to those in the NadA5 crystals) and in curved conformations where the deviation from linearity was 30-90°(hairpins or multiple inflections were rarely observed) (Fig. 4C) . As expected from the high sequence conservation (51% identity), TEM suggests that the NadA3 and NadA5 variants share the same topology.
Insights into Full-Length NadA3 and NadA5 from Homology Modeling.
Full-length in silico models of NadA3 and NadA5 were generated using structure-based sequence alignments of the five NadA variants, along with predictions and manual analyses of coiledcoil periodicities, and omitting regions where sequence analyses showed loss or low probability of coiled-coil formation. Fulllength NadA3 and NadA5 have different overall lengths, with NadA3 extending for ∼400 Å and NadA5 for ∼270 Å, predominantly because of the 81-residue difference in the stalks ( Fig. 5A and Fig. S1B ). A map of sequence conservation between NadA variants reveals a patch of highly conserved residues in the N-terminal head domain in addition to the wholly conserved transmembrane β-barrel. Specifically, although the apical region of the head domain is less conserved, the grooves formed between the wing-like protrusions and the coiled-coil are mostly conserved, suggesting that this basal head region is of particular interest for future functional studies (Fig. 5B ).
Bactericidal mAb 33E8 Is Specific for NadA Group I Variants. Despite sharing a similar 3D fold, NadA group I variants are not crossreactive with NadA group II variants (11) . To investigate the molecular basis for this lack of cross-reactivity, epitope-mapping experiments were performed using the bactericidal mAb 33E8 specific for group I variants. mAb 33E8 originally was obtained from mice immunized with NadA1 and displayed binding to purified recombinant NadA1, 2, and 3 but not to NadA4 and 5 by surface plasmon resonance (SPR) experiments (Fig. S8) . Similarly, FACS analyses showed that mAb 33E8 bound to meningococcal strains expressing NadA variants 1, 2, and 3 but not to a strain that expresses NadA5. Finally, in a serum bactericidal assay (SBA) experiment, mAb 33E8 elicited positive bactericidal titers (>2,048) only against meningococcal strains DE11445, 5/99, and NMB, which express NadA variants 1, 2, and 3, respectively.
Bactericidal mAb 33E8 Binds to the NadA3 Head Domain. SPR experiments performed on different NadA3 fragments showed that both full-length NadA3 and the constructs containing the head+stalk bound to mAb 33E8 with high affinity. In contrast, all other NadA3 constructs made of the coiled-coil only, as well as those of NadA4 and NadA5 made of head+stalk, were not able to bind to mAb 33E8 (Fig. S8A ). Interestingly, a monomeric construct containing only the head domain (NadA3 A24-V89 ) also bound to mAb 33E8 but with significantly decreased affinity. The binding affinities calculated by SPR for the NadA3 full-length, head+stalk, and head-only constructs revealed interactions with equilibrium binding dissociation constants (K d ) of 0.6 nM, 3.4 nM, and 1.5 μM, respectively (Fig. S8B) . DSC experiments suggested that the head-only construct is unfolded (Fig. S8C) , perhaps explaining the ∼1,000-fold lower affinity observed in SPR. Overall, these data indicate that the head or the head+ stalk region of NadA3 contains the protective epitope recognized by mAb 33E8 and that this epitope is either mutated or absent in NadA4 and Nad5.
Size-exclusion chromatography and nondenaturing nanoelectrospray MS then were used to study the stoichiometry of the 33E8/ NadA3 interaction. We used Fab 33E8 in a high-affinity complex with the NadA3 construct A24-A170. The native mass spectrum of the complex showed that the major species was observed in the 6,300-7,750 m/z range, with a molecular mass ranging from 193.5 to 197.2 kDa, thus in agreement with a single trimer of NadA3 A24-A170 (calculated molecular mass, 50.8 kDa) simultaneously bound to three Fab 33E8 fragments (corresponding to a molecular mass in the range 47.4-49.7 kDa) (Fig. S8D ).
Hydrogen-Deuterium Exchange MS Identified the Protective Epitope on NadA. To locate accurately the epitope targeted by mAb 33E8, we first performed peptide-scanning experiments using overlapping 13mer fragments covering the entire NadA3 vaccine antigen. This approach revealed only one linear peptide recognized by mAb 33E8, made of residues K69-F81 localized on the most solvent-accessible wing region of the homology model of the NadA3 head domain (Fig. 6A ). Subsequently we performed epitope mapping by hydrogen-deuterium exchange (HDX)-MS using the construct NadA3 A24-A170 . The binding of Fab 33E8 induced a significant reduction of deuterium uptake for two nonconsecutive peptides, allowing mapping of an epitope involving segments V36-G50 and I60-A74 and taking into account a third peptide (D75-L93) not affected by deuterium protection ( Fig. 6 B and C) as mapped on the NadA3 homology model.
In summary, epitope mapping by peptide scanning and HDX-MS revealed the location of the binding region of Fab 33E8 on the head domain of NadA, in agreement with SPR measurements. In addition, HDX-MS considerably expands the total epitope previously detected by peptide scanning to include residues V36-G50, which reside on the coiled-coil in the center of the head. This finding strongly suggests a conformational nature of the epitope of 33E8. In addition, these results could explain the residual binding of construct NadA3 A24-V89 to 33E8, which, despite the lack of a proper trimeric folding, still may display poorly structured portions of the epitope in a conformation partially competent for binding.
Discussion
The structure of NadA5 reveals a novel trimeric autotransporter adhesin that has no close homologs among other TAAs or among other proteins present in the Protein Data Bank (PDB) but with an overall architecture reminiscent of several other surface molecules of known pathogens ( Fig. S7 ) (36). A single coiled-coil includes both the apical N-terminal region and the main stalk of NadA5, and a peculiar sequence insertion of 36 residues between the a and d position of the third N-terminal heptad repeat gives rise to wing-like structures without altering the coiled-coil geometry. These lateral protrusions are the most solvent-exposed regions of the head, and mapping of the epitope of the bactericidal mAb 33E8 on the NadA3 homology model shows how residues located in this region contribute to form an Full-length models of NadA3 and NadA5 displaying sequence conservation. (A) Models of NadA3 and NadA5 are shown as cartoons; the stalk is shown in blue, the wing-like insertions of the head domain are shown in green, and the transmembrane anchor is shown in orange. The outer membrane where NadA is anchored is shown as a gray bar. Dashed lines indicate either regions missing in the crystal structure of NadA5 or regions with low sequence homology or unknown secondary structure that were not included in the models. (B) The sequence conservation between NadA3 and NadA5 is mapped onto the surface of the model of NadA3 using a gradient of blue from low (light blue) to high (dark blue). Red surface patches indicate sequence insertions in NadA3 that are missing in NadA5 and thus were omitted from the sequence-conservation analyses. Light-and dark-blue boxes show regions of medium and high conservation, respectively, as described in the main text. The representation in B was generated using ProtSkin (40). BH, basal head; MA, membrane anchor; S1, stalk1; S2, stalk2; TH, top head.
epitope that is likely to be conformational and that is protective, at least in the mouse model used herein.
TEM analysis of the vaccine variant 3 shows how NadA variants share similar structures despite a lack of immunological cross-reactivity. This structural similarity presumably reflects the moderately conserved sequence and the conserved function among NadA variants, in particular the previously demonstrated ability of both NadA3 and NadA4 to bind to Chang cells (11) . TEM imaging also reveals how the coiled-coil stalk of NadA undergoes bending, which presumably confers functional advantages and also may explain the difficulties in crystallizing a longer NadA variant.
Although our analyses confirm the same overall structure for different NadA variants, the lack of immunological crossreactivity between the two groups of variants (11) suggests structural and/or surface-localized differences. First, the fulllength models of NadA3 and NadA5 allow us to discern how the stalks of different variants possess different lengths, slightly different or shifted periodicity in the coiled-coils, and interruptions made of sequences of currently unknown structure. Analyses of sequence conservation also reveal how the apical portion of the head of NadA, although structurally conserved, possesses a low degree of sequence conservation as compared with the rest of the molecule. Therefore it is tempting to speculate that both the top of the head of NadA and the variable stalk regions underlie the lack of cross-reactivity between the two variant groups. Also, sequence conservation of the basal head (BH in Fig. 5B ) of NadA, which contains the protective epitope, shows that this region, although conserved overall, possesses moderate local sequence variability that might help explain the differences in antibody binding (Fig. 6) .
In this study we used a rational, biophysically driven approach to solve the first (to our knowledge) 3D structure of the vaccine antigen NadA, which previously had been recalcitrant to crystallization. Overall, our findings shed light on the architecture of this meningococcal antigen and may help elucidate the molecular mechanism of its biological function. The structure revealed here provides working models that can aid in the interpretation of previous studies and guide further investigation to elucidate fully the function of NadA as both an adhesin and a vaccine antigen. For example, these insights now raise the possibility for a structural vaccinology approach for the design of a more broadly cross-protective antigen, as described previously for the highly variable meningococcal fHbp (37), and/or represent a starting point for an epitope-focused strategy (38). Furthermore, additional structural and epitope-mapping studies to elucidate at high resolution the interaction between antibodies generated by human immunization with NadA are ongoing and promise to deliver a deeper understanding of the role of NadA in the human immune response to the first (to our knowledge) licensed and broadly protective vaccine against MenB.
Materials and Methods
Cloning, Expression, and Purification. All NadA constructs were PCR-amplified from MenB chromosomal DNA template strains 2996 (NadA3), NGE28 (NadA4), and M01-240320 (NadA5). Full details can be found in SI Materials and Methods.
DSC. Thermal stability experiments of NadA proteins at 10-μM concentration were performed using a MicroCal VP-Capillary DSC instrument (GE Healthcare), with a temperature scan range from 10-110°C, a thermal ramp rate of 180°C/h, and a 4-s filter period. Data were analyzed with Origin 7 software.
Crystallization, Data Collection, and Structure Determination. Crystallization experiments were performed using a Gryphon crystallization robot (Art Robbins Instruments). X-ray diffraction data were collected at the Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland) beamline X06DA on a Pilatus 2M detector. The NadA5 structure was solved by the SAD method. Data collection and refinement statistics are reported in Table S1 . Atomic coordinates have been deposited in the PDB (ID code 4CJD). Figures were generated using PyMOL (www.pymol.org). Full details can be found in SI Materials and Methods.
Negative Stain TEM. NadA3 Δ351-405 was loaded onto glow-discharged 200-square mesh copper/nickel grids and observed using a TEM Tecnai G2 spirit transmission electron microscope (FEI). Images were collected with a CCD camera, Olympus SIS Morad data collect 2K*4K. Full details can be found in SI Materials and Methods.
In silico Molecular Modeling of Full-Length NadA3 and NadA5. Amino acid sequences of the translocation domains of NadA3 and NadA5, residues 86- 345 and 85-264, respectively, were threaded onto the crystallographic coordinates of the translocation domain of the trimeric autotransporter Hia (PDB ID code 3EMO). Full details can be found in SI Materials and Methods.
Antibody Generation and Fab Purification. The murine IgG2b isotype mAb 33E8 was produced and purified by Areta International. The antigen-binding fragment (Fab 33E8) was prepared by papain digestion of mAb 33E8 followed by purification using a Protein A column (Thermo Scientific). Full details can be found in SI Materials and Methods.
SPR. All SPR experiments were performed using a Biacore T200 instrument (GE Healthcare) at 25°C. Full details can be found in SI Materials and Methods.
Complement-Mediated Bactericidal Activity. Bactericidal activity of mAb 33E8 was evaluated against strains DE11445, 5/99, and NMB, which express NadA variants 1, 2, and 3 respectively. The bactericidal activity was defined as the mAb concentration that resulted in a 50% decrease in colony-forming units per milliliter after 1-h incubation in the reaction mixture compared with the colony-forming units per milliliter in negative control wells at time 0. Full details can be found in SI Materials and Methods.
Flow Cytometry-FACS. The ability of mAb 33E8 to bind surface-exposed variants of NadA on live bacteria was determined by FACS analysis. Full details can be found in SI Materials and Methods.
Nondenaturing Nanoelectrospray MS. NadA samples at 100-μM concentration were analyzed on a SynaptG2 HDMS mass spectrometer (Waters) equipped
Epitope Mapping by Synthetic Peptide Scanning. Screening of a cellulosebound peptide library of NadA3 fragments for binding to mAb 33E8 was performed as described previously (39). Full details can be found in SI Materials and Methods.
Epitope Mapping by HDX-MS. The averaged deuterium exchange behaviors of 19 peptides covering 100% of the NadA3 A24-A170 sequence were measured at different time points (from 30 s to 30 min) in the absence or presence of Fab 33E8. Binding experiments were facilitated by working at low temperature (on ice, 0°C). Full details can be found in SI Materials and Methods.
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Malito et al. 10 .1073/pnas.1419686111 SI Materials and Methods. Cloning, Expression, and Purification. PCR products encoding NadA proteins with a 6His tag at the C terminus were cloned using the polymerase incomplete primer extension cloning method (1) in the pET21b + expression vector (Novagen). After sequencing, each plasmid was transformed into E. coli BL21 (DE3) cells (Novagen) for protein production. Expression of NadA constructs was performed either in rich medium (LB) at 30°C or in high-throughput complex medium 3 [30 g/L yeast extract, 15 g/L glycerol, 20 g/L K 2 HPO 4 , 5 g/L KH 2 PO 4 , 0.5 g/L MgSO 4 (pH 7.2)] at 27°C for 30 h. Purifications were performed by nickel affinity using HisTrap, Q HP anion exchange, and preparative size-exclusion chromatography [Superdex 75 (16/60)] columns (GE Healthcare) in final buffer containing 20 mM Tris·HCl, 150 mM NaCl (pH 8.0). Sample purity was assessed by reversephase HPLC, and integrity was determined on an analytical sizeexclusion HPLC TSG G3000SWxl column (Tosoh Bioscience).
Crystallization, Data Collection, and Structure Determination. Crystallization experiments were performed by the sitting-drop method, using 96-well low-profile crystallization plates, mixing equal volumes (0.2 μL) of proteins at ∼20 mg/mL and reservoir solutions from six different commercial screens. Initial crystal hits appeared after 4 wk for construct NadA4 D24-R219 , from condition E10 of the Hampton Research PEG/ION screen containing 8% Tacsimate (pH 4.0) and 20% PEG3350. These crystals dissolved in their original drop at 20°C over 30 d of incubation. Optimization using pH gradients of Tacsimate, concentration gradients for both Tacsimate and PEG3350 and protein concentration led to reproducible crystals using 10% Tacsimate (pH 4.0), 20% PEG3350. Further crystallization screens were performed using the additive screen from Hampton Research. Before data collection, several crystals were soaked in different cryoprotectant solutions and were cooled to 100 K in liquid nitrogen; the best results were obtained using 10-20% ethylene glycol. Diffraction screenings of more than 100 crystals of NadA4 D24-R219 resulted in one native dataset collected at ∼4 Å resolution. The overall quality of this dataset was very low, because it was affected by disorder and severe anisotropy and with space group P1. Because of the weak sequence similarity with available TAA structures found in the PDB, we were not able to solve the structure of NadA4 D24-R219 using this initial native dataset by molecular replacement. Also, because of the absence of any Met or Cys residues in the sequence of NadA, we attempted soaks of heavy atoms and halides. However, the low-resolution diffraction, intrinsic disorder, and anisotropy of these crystals did not allow us to measure significant anomalous signals.
Although the overall quality of these initial crystals of NadA4 D24-R219 could not be improved notably by further optimization steps, the use of construct NadA5 D24-R220 under the same conditions with 10% Tacsimate (pH 4.0) and 20% PEG3350 immediately yielded improved crystals, as judged by inspection under the microscope. Furthermore, the use of additive screens allowed us to obtain numerous crystals of NadA5 D24-R220 that were shaped as elongated plates with the approximate dimensions 800 × 140 × 50 μm. An initial native dataset at 2.0-Å resolution was collected on a crystal of the NadA5 D24-R220 construct with excellent overall quality and space group R 3 2 (H). In this case, also, we were not able to solve the structure of NadA5 D24-R220 by molecular replacement, prompting us to use heavy atoms and halide soaking for experimental de novo phasing by SAD or MAD. Soaking experiments were performed using solutions containing a slightly more concentrated crystallization mother liquor, made of 12% Tacsimate (pH 4.0) and 22% PEG 3350, supplemented with variable concentrations of derivatives from the lanthanide phasing kit from NatX-ray, the Magic Triangle phasing kit from Jena Bioscience, or manually made stock solutions of NaI, NaBr, KI, and KBr. Incubation times varied from a few seconds up to 5 min, and concentrations of soaked derivatives varied from 100 mM to 1 M. All crystals used for soaking experiments then were back-washed in mother liquor and cryoprotectant (10-20% ethylene glycol) before freezing in liquid nitrogen to ensure that no unspecific, unbound, heavy atoms or halides were present that could interfere with the measurement of anomalous signal. Although fluorescence scans on bromine-and lanthanide-soaked crystals confirmed the incorporation of derivatives in several crystals, derivative datasets from these crystals collected at their respective edges did not allow structure determination. However, data collections of crystals soaked in 1 M sodium iodide performed at a wavelength of 1.54 Å to maximize the anomalous signal while reducing radiation damage resulted in one derivative dataset at 2.05-Å resolution. These data were processed with XDS (2), resulting in an overall R sym of 6.2% (last shell 82.6%) and overall anomalous correlation of 54% extending well up to 2.6 Å (correlation of 26%).
The structure of NadA5 was solved by the SAD method. Substructure solution, phasing, density modification, and initial model building were performed in autosol, phaser, and autobuild of the Phenix suite (3). Subsequent rebuilding and refinement were performed with Coot (4) and phenix.refine; all other crystallographic manipulations were carried out in CCP4 (5). All crystallographic software was compiled, installed, and maintained by SBGrid (6) . The calculated Matthews coefficient of the crystals of NadA5 D24-R220 was 3.12 Å 3 /Da, which corresponds to a solvent content of 60% with one molecule of NadA5 D24-R220 occupying the asymmetric unit. Each single chain of NadA5 D24-R220 sits on a threefold crystallographic axis, so that two additional symmetry-related molecules are positioned to complete the biological homotrimer. The final refined model of NadA5 D24-R220 has R work /R free of 18.2/20.7, excellent geometry, a low clash score, and all residues within the Ramachandran favored region. All data collection and refinement statistics are reported in Table S1 . Atomic coordinates have been deposited in the PDB with ID code 4CJD.
Negative Stain TEM. A 5-μL aliquot of the native, tagless NadA3 Δ351-405 diluted to 0.02 mg/mL was used, loaded onto a glow-discharged 200-square mesh copper/nickel grid coated with a thin carbon film, and allowed to stand for 2 min. Excess solution was blotted off with Whatman filter paper no. 1 (Whatman International Ltd.). The grids first were washed by streaming several drops of ddH 2 O over the grids and then were negatively stained with a solution of 1% buffered uranyl acetate (pH 4.5) for 50 s. The excess liquid was soaked off by Whatman filter paper no. 1, and the grid was left to air dry. The grids were observed using a TEM Tecnai G2 spirit transmission electron microscope (FEI) operating at 80 kV set in low-dose conditions and a magnification of 220,000×. Images were collected with an Olympus SIS Morad 2K*4K CCD camera. Images taken at 220,000× magnification first were analyzed for defocus (1.1-3.2 μm) and contrast transfer function (CTF) using the Medical Research Council program CTFFIND3 (7). Single NadA3 particles were picked semiautomatically from digitized images using the Boxer tool from the EMAN software package (8) . Direct measurement of NadA3 homotrimers using command-measure from the EMAN software (9, 10) clearly showed that the homotrimeric structure displayed size homogeneity. Image phases were corrected for the effect of the CTF in IMAGIC 5 (11) at a box of 100 × 100 pixels (corresponding to a box of 146 × 146 Å and a step size of 1.46 Å per pixel in IMAGIC5).
In Silico Molecular Modeling of Full-Length NadA3 and NadA5. Once the translocation domains of NadA3 and NadA5 were threaded onto the coordinates of Hia (PDB code 3EMO) (12), the NadA5 stalk was extended to include residues 138-220 that were not observed in the crystal structure by using the coordinates of its N-terminal coiled-coil (residues 27-137) as a template. The coiled-coil heptad a-g periodicity observed in the structure was used as a reference to align the NadA sequence to be modeled in frame with the sequence of the template. The final model of NadA5 includes residues 27-137, corresponding to those observed in the crystal structure, 147-161, and 186-324, with gaps of fragments 136-156 and 162-185 that correspond to regions of low probability or unclear coiled-coil periodicity. The experimental crystallographic structure of NadA5 then was used as a template to model fragment 27-170 of NadA3, which from sequence alignment corresponds to the visible coiled-coil (27-137) of NadA5 with the addition of one long insertion (residues 106-137, NadA3 numbering) starting at residue 104 (NadA5 numbering). The stalk region of NadA3 then was extended to residue 330 following the procedure described for NadA5. However, as for NadA3, regions where the coiled-coil probability was low (namely, residues 105-107, 151-160, 218-223, and 267-287) were omitted. Both full-length models were subjected to manual refinement to eliminate major steric clashes on side chains and then to energy minimization with the Gromos 43B1 force field (13) .
Antibody Generation and Fab Purification. Purified recombinant NadA protein from serogroup B N. meningitidis strain MC58 was used to immunize 4-to 6-wk-old female CD1 mice. The first dose was a 50-μg injection with Freund's complete adjuvant; the second, third, and fourth doses, at days 14, 21, and 33, were 25 μg each administered with Freund's incomplete adjuvant. After 1 wk (on day 39), anti-NadA titers were measured in mice sera using ELISA plates coated with the purified recombinant protein and anti-IgG, anti-IgG2a, or anti-IgG2b as the secondary antibodies. A fifth dose was administered without adjuvant, and the mice were killed 5 d later. Their spleen cells were fused with myeloma cells (NS0). After a 2 wk incubation in hypoxanthineaminopterin-thymidine selective medium, the hybridoma supernatants were screened for antibody-binding activity by ELISA. Hybridomas secreting anti-NadA antibodies selected on the basis of the results obtained by SBA and FACS analysis in Novartis were cloned by limiting dilution and then were expanded and frozen for subsequent purification of mAbs. The supernatants of the subclones were sent to Novartis for a second screening by SBA and FACS analysis of the hybridomas to be expanded for the purification of mAb. mAb 33E8 was purified from culture supernatant by Protein G affinity columns (GE Healthcare), and after exhaustive dialysis in PBS buffer the concentration was determined by spectrophotometric reading at 280 nm. The mAb subclass was determined using a mouse mAb isotyping kit (Roche).
SPR. For the single-cycle kinetics (SCK) experiments, which are well suited for the measurement of high-affinity binding events (14) , a commercially available Mouse Antibody Capture Kit (GE Healthcare) was used to immobilize rabbit anti-mouse antibodies by amine coupling on a carboxymethylated dextran sensor chip (CM-5; GE Healthcare). An IgG density level yielding ∼10,000 response units (RUs) was prepared. The rabbit anti-mouse IgG was used to capture ∼600 RU mAb 33E8 (molecular mass ∼150 kDa); the mAb capture was highly stable, resulting in a dissociation drift of <2 RU/h. Experimental running buffer contained 10 mM potassium phosphate, 150 mM NaCl, and 0.05% (vol/vol) P20 surfactant (pH 7.4). To determine the equilibrium K d and kinetic parameters, a titration series of five consecutive injections of increasing analyte concentration (maximum concentration of 10, 50, and 5,000 nM for the clones 24-342, 24-170, and 24-89, respectively; flow rate of 30 μL/min) followed by a single final surface-regeneration step with buffer containing 10 mM glycine (pH 1.7) (flow rate of 10 μL/min) was performed using the standard SCK method (14) implemented by Biacore T200 Control Software (GE Healthcare). For initial comparisons of NadA constructs and variants binding to captured mAb 33E8, single equimolar injections of NadA proteins at a concentration of 100 nM were performed with a flow rate of 30 μL/min. An anti-mouse antibody-coated surface without captured mAb 33E8 was used as the reference channel. A blank injection of buffer only was subtracted from each curve, and reference sensorgrams were subtracted from experimental sensorgrams to yield curves representing specific binding. The data shown are representative of at least two independent experiments. SPR data were analyzed using the Biacore T200 Evaluation software (GE Healthcare). SCK experiments were performed in duplicate, and each sensorgram was fitted with the 1:1 Langmuir binding model, including a term to account for potential mass transfer, to obtain the individual k on and k off kinetic constants; the individual values then were combined to derive the single averaged K d values reported. Additional details of SPR data analysis have been reported previously (15) .
Complement-Mediated Bactericidal Activity. N. meningitidis strains were grown overnight on chocolate agar plates (Biomerieux) at 37°C, 5% CO 2 , and then were used to inoculate 7 mL of MullerHinton broth medium supplemented with 0.25% glucose to reach the OD 600 of ∼0.05. Cultures were incubated for ∼2 h at 37°C with shaking until early log phase (OD 600 of ∼0.25). The bactericidal activity of mAbs was evaluated against strains DE11445, 5/99, and NMB, which express NadA variants 1, 2, and 3, respectively. Early log-phase cultures of bacteria were diluted in Dulbecco's PBS (Sigma) containing 1% BSA and 0.1% glucose (assay buffer) at a working dilution of 10 4 -10 5 cfu/mL. Bacteria were incubated with serial twofold dilutions of test mAb (0.25-0.0005 μg/mL) and 25% baby rabbit complement (Cederlane).
Flow Cytometry-FACS. N. meningitidis strains DE11445, 5/99, NMB, and IB4846, carrying NadA variants 1, 2, 3, and 5, respectively, were grown overnight on chocolate agar plates (Biomerieux) at 37°C, 5% CO 2 . Colonies were picked from the overnight plate and suspended in Muller-Hinton broth until the OD 600 reached ∼0.5. Then 1 mL of suspension was centrifuged, and the bacterial pellet was suspended in PBS plus 1% BSA. Fifty microliters of suspended bacteria were incubated for 1 h with 10 μg/mL mAb in a reaction volume of 100 μL. The binding of mAb 33E8 was detected using an anti-mouse (whole-molecule) FITC-conjugated antibody (Sigma) at a 1:100 dilution. All incubations were performed at room temperature. Before flow cytometry analysis, bacteria were fixed with 0.5% formaldehyde in PBS buffer for 1 h. A polyclonal serum from mice immunized with NadA variant 3 was used as positive control at a dilution of 1:100, and bacteria incubated with PBS plus 1% BSA were used as negative control.
Nondenaturing Nanoelectrospray MS. NadA samples were buffer exchanged against 250 mM ammonium acetate (pH 8.0) using Zeba spin desalting columns with a 7-kDa molecular mass cutoff (Thermo Scientific). A SynaptG2 HDMS mass spectrometer (Waters) equipped with a nano-ESI source was used, and the instrument was calibrated in resolution mode (m/z 500−9,000) using a 100 mg/mL cesium iodide solution. Spectra were acquired in positive mode for 5-30 min to obtain a good signal-to-noise ratio and were processed with MassLynx 4.1 software with minimal smoothing.
Epitope Mapping by Synthetic Peptide Scanning. One hundred twenty distinct peptides, each of 13 residues, with a neighbor overlap of 10 residues, and representing the entire mature NadA3 ectodomain protein were synthesized and spotted onto nitrocellulose membranes, and mAb 33E8 was coincubated with the library. An alkaline phosphatase-conjugated goat anti-mouse antibody was used for detection of binding.
Epitope Mapping by HDX-MS. Deuterium oxide (99.9 atom % D), sodium deuteroxide, deuterium chloride, acetonitrile, and Glufibrinogen peptide were all purchased from Sigma Aldrich and used without further purification.
Sample preparation for HDX-MS analysis. The antigen/Fab complex was formed by adding 200 pmol of NadA to the Fab, using a molar ratio of 1:1, first incubated for 30 min at room temperature and then for 10 min on ice before the deuteration was performed on ice. The labeling reactions were performed on ice by adding the proper deuterated buffer (PBS with a pD of 7.4), reaching a deuterium excess of 82.6%. Over the time course of the experiment (ranging from 30 s to 30 min), 30 μL of the sample were removed and quenched with the same volume of an ice-cold 200 mM sodium phosphate buffer (added with 4 M guanidinium chloride) to dissociate the antigen/Fab complex and to lower the pH to 2.4. The quenched aliquots were frozen immediately in liquid nitrogen and stored at −80°C for less than 24 h. A control experiment without Fab was prepared using the conditions previously described (PBS was used instead of the antibody preparation).
Local HDX-MS analysis. Labeled samples were thawed rapidly to 0°C and injected into a Waters nanoACQUITY ultra-performance liquid chromatographic (UPLC) system with HDX technology. The injector, switching valve, columns, solvents, and all associated tubing were at 0°C to limit back-exchange. For local HDX-MS, protein samples were digested online for 2.5 min at 20°C with a flow rate of 200 μL/min using a Poroszyme Immobilized Pepsin Cartridge (2.1 × 20 mm; Applied Biosystems) equilibrated with 100% buffer A (0.1% formic acid in water). The generated peptides were trapped immediately, concentrated, and desalted using a VanGuard BEH Precolumn (1.7 μm, 2.1 × 5 mm; Waters). Peptides then were separated on an ACQUITY UPLC BEH C18 reverse-phase column (1.7 μm, 1.0 × 100 mm; Waters) with a linear gradient from 15-45% solvent B [acetonitrile/water (9:1), 0.1% formic acid] over 6.8 min at 40 μL/min. Mass spectra acquisition and interpretation. Mass spectra were acquired in resolution mode (m/z 100-2,000) on a Waters SynaptG2 mass spectrometer equipped with a standard ESI source. Mass accuracy was ensured by continuously infusing a Glu-Fib solution (600 fmol/μL in 50% acetonitrile, 0.1% formic acid) through the reference probe of the ESI source. The identity of each peptide was confirmed by mass spectrometry elevated energy (MS E ) analyses. MS E was performed directly by a succession of low-collision (6-V) and high-collision (25-V) energies in the transfer region of the mass spectrometer. All fragmentations were performed using argon as the collision gas. Data were processed using Protein Lynx Global Server 2.5 (Waters), and each fragmentation spectrum was inspected manually to confirm the assignment. The DynamX software (Waters) was used to select the peptides considered for the analysis and to extract the centroid mass of each of them and for each charge state as a function of the labeling time. Only the peptic peptides present in at least three repeated digestions of the unlabeled proteins were considered for the analysis. . NadA sequence variants and alignment. (A) The neighbor-joining tree reconstructed using the bootstrap test of phylogeny of six different amino acid sequences shows the subdivision of NadA protein variants in two groups, with NadA1, 2, and 3 in one group and NadA4, 5 and 6 in the other group. (B) Sequence identities between NadA variants are shown in gray shades. The regions of NadA5 observed in the crystal structure of fragment A24-R220 are underlined, and the insertion forming the wing-like structures is underlined and in italic font. The observed (between residues A34 and A137) and predicted (between residues 138 and 245) coiled-coil periodicity of NadA5 is shown by dark purple shading for residues in a and d, and predicted coiled-coil periodicity of NadA3 is shown with cyan shading. Yellow and red shading indicates segments of the coiled-coil regions of NadA3 and NadA5, respectively, where sequences with coiled-coil periodicity are lacking. Fig. S2 . Domain organization and constructs of NadA. All constructs of NadA3, 4, and 5 used for thermostability and structural studies are shown in A and B. Constructs of NadA3 used for epitope mapping are shown in C. Each expression construct had a C-terminal 6His tag to enable affinity purification. The predicted domain organization and domain boundaries as detected by sequence analyses and sequence similarities with other TAAs are shown schematically. Fig. S3 . Thermostability of NadA variants with variable coiled-coil length. (A) DSC profiles of initial NadA3 and NadA4 constructs. (B) Thermostability of NadA4 constructs with a progressively reduced C-terminal coiled-coil and of an NadA "head-only" construct. Fig. S4 . Crystal packing of NadA5. (A) NadA5 trimers are arranged in antiparallel columns along the c axis of the crystal. Shown here is a section of the content of the unit cell of crystals of NadA5 (bc face). NadA is depicted as a cartoon in which the coiled-coil/stalk region is colored blue and the wing-like structures of the head domain are colored green. The stalks of symmetry-related trimers run in opposite directions toward a region of very few crystal contacts corresponding to the gap of unobserved or disordered residues (I138-T198) and resulting in an unusual discontinuity of crystal packing covering a distance of ∼50 Å. The section of the coiled-coil (residues I138-T198) that could not be adequately fitted because of low-σ electron density clearly bridges this gap in the crystal packing. (B) Two symmetry-related antiparallel trimers of NadA5 are shown to highlight the arrangement and contacts mediated by the head-like domain. The uncoiled C-terminal short fragments are also shown. (C) View from top (ab face) of the crystal packing of NadA5 showing one trimer as a red cartoon and all other trimers colored as in A and B. (D) Slab view of C to highlight the position of the wing-like structures (green) of three parallel NadA trimers that sandwich each of the three unwound short helices (red) made of residues T199-A210. Three trimers of NadA5 oriented from N→C toward the viewer and their wing-like structures of the head that sandwich the short C-terminal fragments of a successive symmetry-related trimer are marked with circled dots colored black, blue, and orange. Faint red lines in A, C, and D show the unit cell. All structure figures were generated using PyMOL (www.pymol.org). Sequence alignment between NadA3 and NadA5, with the location of the heptad repeats of the coiled-coil observed in the crystal structure of NadA5 marked below the sequence with the motifs abcdefg, and with a and d in yellow and magenta boxes, respectively. Residues belonging to the insertion between residues 49 and 84, which make the wings of the head, are shown with green fonts. (C) Structural comparison between NadA5 (blue and green cartoon), SadA (PDB 2WPQ) (cyan), and UspA1 (PDB 2QIH) (orange). Optimal superpositions were obtained when matching Cα atoms of residues N106-A137 of NadA5 onto Legend continued on following page N488-S519 of SadA, and N601-D632 of UspA1, which align coiled-coil heptad repeats by keeping fixed an Asn of N@d layers found in all three structures. These superpositions result in rmsd values of 0.54 Å and 0.57 Å for SadA and UspA1, respectively, and in a deviation of ∼4°in the helical angle of the superposed helices. (D) Plots of the coiled-coil periodicity (Top), pitch (Middle), and radius (Bottom) of the observed fragment P27-A137 of NadA5, calculated with the program TWISTER (16) and shown as a function of residue number. The green-shaded region corresponds to the insertion of residues N49-G84, and the region shaded in red shows deviations of the geometry of the coiled-coil nearby residues N134 and K135; these deviations likely are induced by the lack of coiled-coil periodicity immediately toward the C terminus. S8 . Binding of mAb 33E8 to NadA3. (A) The affinity of NadA fragments for immobilized mAb 33E8 was assessed by single injections at 100-nM concentration. High binding responses (RU >100) were observed for NadA3 clones A24-G342, A24-K268, and A24-A170. Some residual binding to NadA3 A24-V89 was observed also (30 RU). Essentially no binding was observed to NadA3 clones T91-G342, T140-G342, T179-G342, to NadA4 clone A24-A260, or to NadA5 A24-R220. (B) SPR sensorgrams for SCK experiments showing that full-length NadA3 A24-G342 and NadA3 A24-A170 bind to mAb 33E8 with low-nanomolar affinity, whereas NadA3 A24-V89 shows an ∼1,000-fold weaker binding which required a steady-state fitting analysis. Experimental data (colored lines) and the calculated curves (black lines) were fitted to a 1:1 binding model. A table summarizing the kinetic binding parameters determined above is shown also. (C) DSC profiles of NadA clones used for studying the binding of mAb 33E8. A large peak with T m = 44°C (magenta) shows that the NadA3 A24-G342 is stably folded. Smaller peaks were observed with T m = 38°C for clone NadA3 A24-T170 (blue) and T m 40-43°C for the NadA3 clones T91-G342, T140-G342, and T179-G342
Legend continued on following page (red, gray, and purple), indicating that these clones retain tertiary structure but are slightly less stable than the full-length construct. The NadA3 A24-V89 protein displayed a completely flat DSC profile (yellow) with no melting transition, indicating that it does not have a stable tertiary structure, i.e., is likely to be unfolded. (D) Stoichiometry of the binding of NadA to Fab 33E8 by nondenaturing nanoelectrospray MS. The nano-ESI mass spectrum of the complex NadA3 A24-A170 :Fab 33E8 under native conditions is shown. The protein and the Fab also are present alone as dissociated species because of the ionization conditions in nondenaturing MS. The NadA monomer is represented by the charged state series from +7 to +11 in the 1,250-2,600 m/z range with a corresponding molecular mass of 16.9 kDa. The Fab, which exists in different species, probably because of unspecific cleavage of the relative mAb 33E8, corresponds to the charged state series from +11 to +15 in the 2,800-4,400 m/z range with a molecular mass ranging from 47.4-49.7 kDa. The measured molecular mass of the NadA trimer bound to three Fabs, ranging from 193.5-197.2 kDa, correlates with the expected mass of the different complex combinations and is reported by the charged state series from +26 to +30 in the 6,300-7,750 m/z range. All the NadA trimer apparently is bound to the Fabs and is not present in the spectrum. ‡ Data from autosol (3). § R work = ΣjjF(obs)j − jF(calc)jj/ΣjF(obs)j; R free = as for R work but calculated for 5.0% of the total reflections that were chosen at random and omitted from refinement.
